Skip to content

Using data mining and network pharmacology to analyze Professor Huang Minghan's application of the "Tiao Pi Xie Shu" theory in treating chronic atrophic gastritis, focusing on medication patterns and mechanisms of efficacy.

Using data mining and network pharmacology to analyze Professor Huang Minghan's application of the "Tiao Pi Xie Shu" theory in treating chronic atrophic gastritis, focusing on medication patterns and mechanisms of efficacy.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000483
Enrollment
Unknown
Registered
2026-03-09
Start date
2026-01-14
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic atrophic gastritis

Interventions

Observation group:Please fill in the Clinical Four Diagnostic Methods Information Collection Form.

Sponsors

Fujian University of Traditional Chinese Medicine Affiliated Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria of CAG in both traditional Chinese and Western medicine; (2) For patients with multiple recurrent visits, the initial prescription is taken; (3) Regularly takes the herbal decoction prescribed by Professor Huang Minghan, with good compliance; (4) Complete medical records; (5) Age between 18 and 80 years old; (6) Patients sign the "Informed Consent Form" and voluntarily agree to participate in this clinical study. (Note: All of the above conditions must be met.)

Exclusion criteria

Exclusion criteria: (1) Those with severe digestive system disorders such as gastrointestinal ulcers, bleeding, or malignant tumors; (2) Individuals with severe primary diseases of the heart, brain, liver, lungs, kidneys, or hematopoietic system; (3) Patients with mental illness or severe conditions that affect their survival; (4) Pregnant or breastfeeding women; (5) Those currently taking other medications for treatment (e.g., nonsteroidal anti-inflammatory drugs, prokinetic drugs). (Note: Any of the above conditions warrant exclusion.)

Design outcomes

Primary

MeasureTime frame
Patient's clinical symptoms related to chronic atrophic gastritis - location of epigastric pain.;Patient clinical symptoms associated with chronic atrophic gastritis - nature of pain;The patient has clinical symptoms associated with chronic atrophic gastritis, specifically chest and abdominal symptoms.;Clinical symptoms related to chronic atrophic gastritis in patients - Etiology of symptoms;Clinical symptoms related to chronic atrophic gastritis in patients - Factors aggravating or alleviating symptoms.;The patient's clinical symptoms associated with chronic atrophic gastritis - taste.;The patient's clinical symptoms related to chronic atrophic gastritis - vomiting condition.;Patient with chronic atrophic gastritis-related clinical symptoms - salivary condition.;Clinical symptoms related to chronic atrophic gastritis in patients - Sleep condition;The patient's clinical symptoms related to chronic atrophic gastritis - stool condition.;The patient's clinical symptoms related to chronic atrophic gastritis - urination status.;Patient with chronic atrophic gastritis-related clinical symptoms - physical condition;Patient's clinical symptoms related to chronic atrophic gastritis - dietary habits;Patient clinical symptoms associated with chronic atrophic gastritis - head, face, ear, and eye conditions.;Patient's general condition - Tongue coating and tongue body condition -;General condition of the patient - Pulse condition;General condition of the patient - fever and chills;General condition of the patient – Sweating condition;General condition of the patient - Mental and emotional well-being;General condition of the patient - general observation;The general condition of the patient - abdominal palpation;General condition of the patient - olfactory examination;

Countries

China

Contacts

Public ContactYang Kai

Fujian University of Traditional Chinese Medicine Affiliated Second People's Hospital

2945474800@qq.com18859139478

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026